Heba Elsayed Abd Elhaliam Baioumy
Lecturer
The Potential Effects of Quercetin-Loaded Nanoliposomes on Amoxicillin/Clavulanate-Induced Hepatic Damage: Targeting the SIRT1/Nrf2/NF-B Signaling Pathway and Microbiota Modulation
• 2023
Publication Information
Authors
Mahran Mohamed Abd El-Emam 1, Mahmoud Mostafa 2 , Amina A. Farag 3 , Heba S. Youssef 4 ,
Azza S. El-Demerdash 5 , Heba Bayoumi 6, Mohammed A. Gebba 7,8, Sawsan M. El-Halawani 9,
Abdulrahman M. Saleh 10 , Amira M. Badr 11,* and Shorouk El Sayed 12
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Amoxicillin/clavulanate (Co-Amox), a commonly used antibiotic for the treatment of
bacterial infections, has been associated with drug-induced liver damage. Quercetin (QR), a naturally
occurring flavonoid with pleiotropic biological activities, has poor water solubility and low
bioavailability. The objective of this work was to produce a more bioavailable formulation of QR
(liposomes) and to determine the effect of its intraperitoneal pretreatment on the amelioration of
Co-Amox-induced liver damage in male rats. Four groups of rats were defined: control, QR liposomes
(QR-lipo), Co-Amox, and Co-Amox and QR-lipo. Liver injury severity in rats was evaluated for all
groups through measurement of serum liver enzymes, liver antioxidant status, proinflammatory
mediators, and microbiota modulation. The results revealed that QR-lipo reduced the severity of
Co-Amox-induced hepatic damage in rats, as indicated by a reduction in serum liver enzymes and
total liver antioxidant capacity. In addition, QR-lipo upregulated antioxidant transcription factors
SIRT1 and Nrf2 and downregulated liver proinflammatory signatures, including IL-6, IL-1 , TNF- ,
NF-B, and iNOS, with upregulation in the anti-inflammatory one, IL10. QR-lipo also prevented
Co-Amox-induced gut dysbiosis by favoring the colonization of Lactobacillus, Bifidobacterium, and
Bacteroides over Clostridium and Enterobacteriaceae. These results suggested that QR-lipo ameliorates
Co-Amox-induced liver damage by targeting SIRT1/Nrf2/NF-B and modulating the microbiota.
bacterial infections, has been associated with drug-induced liver damage. Quercetin (QR), a naturally
occurring flavonoid with pleiotropic biological activities, has poor water solubility and low
bioavailability. The objective of this work was to produce a more bioavailable formulation of QR
(liposomes) and to determine the effect of its intraperitoneal pretreatment on the amelioration of
Co-Amox-induced liver damage in male rats. Four groups of rats were defined: control, QR liposomes
(QR-lipo), Co-Amox, and Co-Amox and QR-lipo. Liver injury severity in rats was evaluated for all
groups through measurement of serum liver enzymes, liver antioxidant status, proinflammatory
mediators, and microbiota modulation. The results revealed that QR-lipo reduced the severity of
Co-Amox-induced hepatic damage in rats, as indicated by a reduction in serum liver enzymes and
total liver antioxidant capacity. In addition, QR-lipo upregulated antioxidant transcription factors
SIRT1 and Nrf2 and downregulated liver proinflammatory signatures, including IL-6, IL-1 , TNF- ,
NF-B, and iNOS, with upregulation in the anti-inflammatory one, IL10. QR-lipo also prevented
Co-Amox-induced gut dysbiosis by favoring the colonization of Lactobacillus, Bifidobacterium, and
Bacteroides over Clostridium and Enterobacteriaceae. These results suggested that QR-lipo ameliorates
Co-Amox-induced liver damage by targeting SIRT1/Nrf2/NF-B and modulating the microbiota.